Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study Meeting Abstract
| Authors: | Hyman, D.; Hendifar, A.; Chung, H. C.; Maio, M.; Leary, A.; Spanggaard, I.; Rhee, J.; Marton, M.; Chen, M.; Krishnan, S.; Shapira, R. |
| Abstract Title: | Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900205 |
| DOI: | 10.1158/1538-7445.Am2019-ct229 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT229 -- Source: Wos |
